Skip to main content
KITL
OTC Life Sciences

Kisses from Italy Pivots to Biologics & Longevity via Regen Health Merger, Appoints New CEO for Aggressive 2026 Expansion

feedReported by TMX Newsfile
Sentiment info
Positive
Importance info
9
Price
$0.003
Mkt Cap
$1.182M
52W Low
$0
52W High
$0.007
Market data snapshot near publication time

summarizeSummary

Kisses from Italy (KITL) announced a transformative business combination with Regen Health Physicians, signaling a strategic pivot into the high-growth biologics and longevity sector. Dr. MD Ajit Dhaliwal, founder of Regen Health, has been appointed as the new CEO, and the company unveiled an aggressive 2026 expansion strategy, including initial clinics in major metropolitan markets and a broader franchise rollout. This event is highly material for the micro-cap company, fundamentally changing its business model and positioning it to capitalize on the rapidly expanding medical spa and peptide therapeutics markets. Traders will closely monitor the execution of this ambitious expansion plan, the successful integration of Regen Health Physicians, and the financial performance of the new medical platform.

At the time of this announcement, KITL was trading at $0.00 on OTC in the Life Sciences sector, with a market capitalization of approximately $1.2M. The 52-week trading range was $0.00 to $0.01. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: TMX Newsfile.


show_chartPrice Chart

Share this article

Copied!

feed KITL - Latest Insights

KITL
Apr 16, 2026, 3:36 PM EDT
Source: TMX Newsfile
Importance Score:
9
KITL
Apr 15, 2026, 11:22 AM EDT
Source: TMX Newsfile
Importance Score:
9